Naoki Hijiya

Oita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Histone Deacetylase 10 Inhibitors Suppress Progression of Endometriosis via Activation of Interferon Regulatory Factor 6 and Dachshund Homolog 1.

Histone Deacetylase 10 Inhibitors Suppress Progression of Endometriosis via Activation of Interferon Regulatory Factor 6 and Dachshund Homolog 1.

Journal: The journal of obstetrics and gynaecology research

Published: January 09, 2026

SMYD3-MEK/ERK Axis Contributes to Intestinal Metaplasia and Helicobacter pylori-Associated Gastric Carcinogenesis.

SMYD3-MEK/ERK Axis Contributes to Intestinal Metaplasia and Helicobacter pylori-Associated Gastric Carcinogenesis.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 08, 2025

Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma.

Annexin A8 Drives MEK Inhibitor Resistance, Providing a Druggable Target for Pancreatic Ductal Adenocarcinoma.

Journal: Molecular cancer therapeutics

Published: June 08, 2025

Establishment of a Novel Organoid Line from Esophageal Squamous Cell Carcinoma with Cytoplasmic Vacuoles: Association of Autolysosome Swelling with Vacuole Formation.

Establishment of a Novel Organoid Line from Esophageal Squamous Cell Carcinoma with Cytoplasmic Vacuoles: Association of Autolysosome Swelling with Vacuole Formation.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: April 16, 2025

Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy.

Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy.

Journal: Human cell

Published: September 26, 2023

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors.

IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors.

Journal: Frontiers in oncology

Published: August 04, 2023

Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response.

Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response.

Journal: Cancers

Published: June 09, 2023

Overexpression of VSNL1 Enhances Cell Proliferation in Colorectal Carcinogenesis.

Overexpression of VSNL1 Enhances Cell Proliferation in Colorectal Carcinogenesis.

Journal: Pathobiology : journal of immunopathology, molecular and cellular biology

Published: May 15, 2023

Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma.

Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma.

Journal: Cancer science

Published: February 21, 2023

Efficient Establishment of Bile-Derived Organoids From Biliary Cancer Patients.

Efficient Establishment of Bile-Derived Organoids From Biliary Cancer Patients.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: September 20, 2022

Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.

Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.

Journal: Cancer science

Published: July 01, 2022

Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.

Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: November 12, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026